BioSpace News Archive

Cerevance today announced that Craig Thompson, chief executive officer of Cerevance, will present and host investor meetings at the upcoming 2023 Life Sciences Private Company Showcase.

Araris Biotech AG (“Araris”), a company developing ADCs using its proprietary linker-payload technology, today announced the appointment of Dragan Grabulovski, Ph.D., to acting chief executive officer (CEO).

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2023 financial results on Wednesday, October 25, 2023, prior to the market open.

Acasti Pharma Inc. today announced that it will host a virtual KOL event titled GTX-104: a potential new treatment standard for rare and life-threatening aSAH on Wednesday, October 11, 2023 at 2:00pm ET.

Ocean Biomedical, Inc. (NASDAQ: OCEA ) announced today that it has entered into a non-binding term sheet with its largest stockholder, Poseidon Bio, LLC, majority owned by Dr. Chirinjeev Kathuria, for a proposed debt facility consisting of convertible promissory notes with a principal amount of up to $10 million.

Select Medical Holdings Corporation, will release the financial results for its third quarter ended September 30, 2023 on Thursday, November 2, 2023 after the market closes.

Autobahn Therapeutics today announced that Kevin Finney, President and Chief Executive Officer, will present at the following upcoming investor conferences.

Sonendo , Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the signing of two new strategic partnership agreements with the country’s leading endodontic dental service organizations (DSOs) to expand patient access to a best-in-class root canal experience.

Odyssey Therapeutics, Inc. today announced the appointment of Jeremy Sokolove, M.D., as chief medical officer.

Artelo Biosciences, Inc. announced that H.C. Wainwright will be hosting a virtual medical expert webinar on October 11, 2023 at 12:00 p.m. Eastern Time to discuss the current treatment landscape for cancer-related anorexia and cachexia.